STRATA Skin Sciences Inc (SSKN) Receives Average Recommendation of “Strong Buy” from Analysts

STRATA Skin Sciences Inc (NASDAQ:SSKN) has earned an average broker rating score of 1.00 (Strong Buy) from the three analysts that provide coverage for the company, Zacks Investment Research reports. Three research analysts have rated the stock with a strong buy recommendation.

Brokers have set a 12 month consensus price target of $5.67 for the company and are forecasting that the company will post ($0.02) EPS for the current quarter, according to Zacks. Zacks has also given STRATA Skin Sciences an industry rank of 51 out of 256 based on the ratings given to its competitors.

Several research analysts have issued reports on SSKN shares. Zacks Investment Research upgraded STRATA Skin Sciences from a “hold” rating to a “buy” rating and set a $2.75 target price for the company in a research report on Friday, May 17th. Northland Securities restated a “buy” rating and set a $7.00 target price on shares of STRATA Skin Sciences in a research report on Tuesday, May 14th. Finally, ValuEngine lowered STRATA Skin Sciences from a “buy” rating to a “hold” rating in a research report on Monday, April 1st.

Shares of NASDAQ:SSKN traded down $0.06 during trading hours on Friday, hitting $2.09. 64,664 shares of the company’s stock traded hands, compared to its average volume of 66,167. STRATA Skin Sciences has a 1 year low of $1.45 and a 1 year high of $3.88. The company has a debt-to-equity ratio of 0.22, a quick ratio of 4.03 and a current ratio of 4.54.

Several large investors have recently made changes to their positions in the business. Broadfin Capital LLC boosted its position in shares of STRATA Skin Sciences by 32.0% during the first quarter. Broadfin Capital LLC now owns 2,866,323 shares of the medical device company’s stock valued at $8,169,000 after buying an additional 694,960 shares during the period. Nantahala Capital Management LLC boosted its holdings in shares of STRATA Skin Sciences by 8.2% in the fourth quarter. Nantahala Capital Management LLC now owns 2,768,001 shares of the medical device company’s stock valued at $7,197,000 after acquiring an additional 209,110 shares in the last quarter. Renaissance Technologies LLC boosted its holdings in shares of STRATA Skin Sciences by 14.5% in the first quarter. Renaissance Technologies LLC now owns 1,030,816 shares of the medical device company’s stock valued at $2,938,000 after acquiring an additional 130,700 shares in the last quarter. Meitav Dash Investments Ltd. boosted its holdings in shares of STRATA Skin Sciences by 12.8% in the first quarter. Meitav Dash Investments Ltd. now owns 807,234 shares of the medical device company’s stock valued at $2,314,000 after acquiring an additional 91,418 shares in the last quarter. Finally, Vanguard Group Inc. boosted its holdings in shares of STRATA Skin Sciences by 3,605.7% in the third quarter. Vanguard Group Inc. now owns 593,357 shares of the medical device company’s stock valued at $2,100,000 after acquiring an additional 577,345 shares in the last quarter. Institutional investors and hedge funds own 28.86% of the company’s stock.

About STRATA Skin Sciences

STRATA Skin Sciences, Inc, a medical technology company, focuses on the therapeutic and aesthetic dermatology market. The company operates through three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment, and Dermatology Imaging. Its products include XTRAC laser and VTRAC excimer lamp systems used for the treatment of psoriasis, vitiligo, and other skin conditions; the STRATAPEN MicroSystems, a micropigmentation device; and Nordlys, a multi-technology aesthetic laser device for treating vascular and pigmented lesions.

Featured Story: What is the formula for the cash asset ratio?

Get a free copy of the Zacks research report on STRATA Skin Sciences (SSKN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.